Pharmicell Co Ltd
KRX:005690
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Kinlita Chemical Co Ltd
SZSE:300225
|
CN |
Pharmicell Co Ltd
Capital Expenditures
Pharmicell Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharmicell Co Ltd
KRX:005690
|
Capital Expenditures
-₩7.5B
|
CAGR 3-Years
27%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
-3%
|
|
|
Celltrion Inc
KRX:068270
|
Capital Expenditures
-₩331.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-7%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Capital Expenditures
-₩1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Capital Expenditures
-₩33.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-24%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Capital Expenditures
-₩20.7B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-101%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Capital Expenditures
-₩415.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharmicell Co Ltd
Glance View
Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. The company is headquartered in Seoul, Seoul and currently employs 127 full-time employees. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. The company also provides steam cell storage services, and mesenchymal stem cells (MSCs) used for research areas and others. In addition, the Company engages in the fashion business, which provides women’s and men’s apparels under the brand names of Religion and Day. On March 31, 2013, the Company merged with its wholly owned subsidiary, mainly engaged in the manufacture and sale of medicines.
See Also
What is Pharmicell Co Ltd's Capital Expenditures?
Capital Expenditures
-7.5B
KRW
Based on the financial report for Dec 31, 2025, Pharmicell Co Ltd's Capital Expenditures amounts to -7.5B KRW.
What is Pharmicell Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-3%
Over the last year, the Capital Expenditures growth was -74%. The average annual Capital Expenditures growth rates for Pharmicell Co Ltd have been 27% over the past three years , -68% over the past five years , and -3% over the past ten years .
